Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXY2DK
|
||||
Drug Name |
4-(5-{[3-(3-Chloro-benzyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[d]azepin-1-ylamino]-methyl}-imidazol-1-ylmethyl)-benzonitrile
|
||||
Synonyms |
CHEMBL434879
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C29H26ClN5O
|
||||
Canonical SMILES |
Clc1cccc(CN2CCc3ccccc3C(NCc4cncn4Cc5ccc(cc5)C#N)C2=O)c1
|
||||
InChI |
InChI=1S/C29H26ClN5O/c30-25-6-3-4-23(14-25)19-34-13-12-24-5-1-2-7-27(24)28(29(34)36)33-17-26-16-32-20-35(26)18-22-10-8-21(15-31)9-11-22/h1-11,14,16,20,28,33H,12-13,17-19H2
|
||||
InChIKey |
JUHFBGZNDZFVMC-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.